Tarrin B. Layne

Tarrin Layne practices at Charleston Nephrology Hypertension and Transplant in South Charleston, West Virginia.

Tarrin Layne's NPI, 1891339586, was assigned on November 5, 2019. Tarrin Layne holds West Virginia license 103721.

Tarrin Layne's primary practice is Charleston Nephrology Hypertension and Transplant, at 4825 Maccorkle SW Ave, South Charleston, WV 25309 in Kanawha County. The practice phone is (304) 400-4700.

Tarrin Layne's primary practice is Charleston Nephrology Hypertension and Transplant in South Charleston, West Virginia. Tarrin Layne is also affiliated with Thomas Memorial Hospital. The medical group on file is Charleston Nephrology, Hypertension and Transplant. Dmand AI also links Tarrin Layne to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tarrin Layne practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Tarrin Layne's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Tarrin Layne is licensed in West Virginia.

CMS counts 42 Medicare patients who saw Tarrin Layne in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 4.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tarrin Layne's median patient age at 76, with 45% women.

In 2024, Tarrin Layne wrote 735 Medicare Part D claims for 251 patients. 93% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Tarrin Layne for performance year 2024, reported through an alternative payment model (APM). Tarrin Layne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tarrin Layne as offering telehealth.

CMS Open Payments shows 12 general payments to Tarrin Layne from 6 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $76.